Spot Trading’s NovoCure NVCR Stock Holding History

Spot Trading’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-3,300	Closed	-$28K	–	3036
2016 Q3	$28K	Sell	3,300 -3,100	-48%	-$28.3K	﹤0.01%	2758
2016 Q2	$75K	Buy	+6,400	New	+$80.1K	﹤0.01%	2633

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

HCM

Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CCM

Courage Capital Management Nashville, Tennessee $70.6M AUM 13.29% 1-Year Est. Return

Spot Trading's NVCR Position: Q3 2016 in Review

Spot Trading sold out of NovoCure (NVCR) in Q3 2016, closing a stake of 3,899 shares — an estimated $35.6K sold.

Spot Trading first reported a position in NVCR in Q2 2016 and held it in 1 quarter. The position peaked at $46K in Q2 2016. 63 funds tracked by Wall St. Rank hold NVCR as of Q3 2016.

Spot Trading reported no remaining NovoCure position as of Q3 2016 after selling out during the quarter.
Spot Trading sold 3,899 NovoCure shares in Q3 2016, an estimated $35.6K.
Spot Trading first reported a position in NovoCure in Q2 2016 and held it in 1 quarter.
Spot Trading's NovoCure position peaked at $46K in Q2 2016.
63 funds tracked by Wall St. Rank held NovoCure as of Q3 2016.

Based on Spot Trading's 13F filing for Q3 2016, filed 31 Oct 2016.